Article
KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications.
The Journal of molecular diagnostics : JMD - 1 Jul 2011
Balschun Katharina, Haag Jochen, Wenke Ann-Kathrin, von Schönfels Witigo, Schwarz Nicolas T, Röcken Christoph
Abstract excerpt
Targeted therapy of advanced colorectal carcinoma (CRC) necessitates KRAS genotyping. Because we were interested in diagnostic and therapeutic consequences, we studied the KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary CRCs; in addition, we studied their available metastases. We studied 21 patients with 43 synchronous and 2 metachronous adenocarcinomas of the colorectum (n...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
